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I
am deeply interested in the subject of glycemia/
HbA1c relationships, underlying mechanisms, and
impact on the assessment of glycemic control and
diabetes prevalence. In the article by Soranzo et al.
(1) published in Diabetes, the abstract indicates that
adjusted HbA1c would imply the reclassiﬁcation of about
2% of the subjects in a general Caucasian population.
The table provided in Fig. 3 of that article is displayed
below (Table 1) with the blank spaces ﬁlled with the cor-
responding ﬁgures and my reading of it.
 Undiagnosed diabetes according to fasting plasma glu-
cose 593/10,110 5 5.87%.
 Undiagnosed diabetes according to measured HbA1c
$6.5% 5 (234 1 112)/10,110 5 346/10,110 5 3.42%.
 Undiagnoseddiabetesaccordingto7singlenucleotidepoly-
morphism (SNP)-adjusted HbA1c $6.5% 5 (222 1 96)/
10,110 5 318/10,110 5 3.15%.
At the population level, should diabetes diagnosis be
performed using HbA1c, adjustment for 7 single nucleotide
polymorphisms, would imply a net reclassiﬁcation of 28 out
of 10,110 subjects, an absolute difference in new diagnosis
of 20.27% (3.15–3.42%) and a relative reduction of 27.9%
(20.27/3.42) 3 100.
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TABLE 1
Reclassiﬁcation of diabetes diagnoses performed using HbA1c
when genetic information is taken into account
7 SNP-adjusted
,6.5%* .6.5%* Total
Undiagnosed diabetes
,6.5%* 358 1 359
.6.5%* 13 221 234
Subtotal 371 222 593
Nondiabetes
,6.5%* 9,404 1 9,405
.6.5%* 17 95 112
Subtotal 9,421 96 9,517
Total 9,792 318 10,110
Data are n. *HbA1c.
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